These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 14319659)

  • 1. [COMPARATIVE STUDIES ON THE EFFECT OF SOME ALKYLATING ANTINEOPLASTIC PREPARATIONS ON THE RAT BLOOD].
    IVANOVA NP
    Vestn Akad Med Nauk SSSR; 1964; 19():54-8. PubMed ID: 14319659
    [No Abstract]   [Full Text] [Related]  

  • 2. [INFLUENCE OF ALKYLATING ANTINEOPLASTIC AGENTS ON NARCOSIS].
    DIMEZZA F
    Minerva Anestesiol; 1964 Dec; 30():511-7. PubMed ID: 14267928
    [No Abstract]   [Full Text] [Related]  

  • 3. [COMPARATIVE STUDY OF THE SPECTRUM OF ACTION OF ANTINEOPLASTIC PREPARATIONS OF THE ALKYLATING AGENT GROUP ON TRANSPLANTABLE TUMORS IN MICE].
    BOKAEVA SS
    Biull Eksp Biol Med; 1965 Mar; 59():86-8. PubMed ID: 14310877
    [No Abstract]   [Full Text] [Related]  

  • 4. ALKYLATION OF SYNTHETIC POLYNUCLEOTIDES.
    LUDLUM DB; WARNER RC; WAHBA AJ
    Science; 1964 Jul; 145(3630):397-9. PubMed ID: 14172601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CHANGES IN THE AMOUNT OF SULFHYDRYL COMPOUNDS IN THE BLOOD SERUM AND TISSUES OF TRANSPLANTED RAT TUMORS UNDER THE INFLUENCE OF ANTINEOPLASTIC ALKYLATING PREPARATIONS].
    KULIK GI
    Vopr Onkol; 1964; 10():70-4. PubMed ID: 14259823
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative effects of certain alkylating agents on the proliferation of normal and tumour tissue-haematopoiesis.
    FOX BW; CRAIG AW; JACKSON H
    Acta Unio Int Contra Cancrum; 1960; 16():611-3. PubMed ID: 13824240
    [No Abstract]   [Full Text] [Related]  

  • 7. EXPERIMENTAL CHEMOTHERAPY STUDIES. VII. THE EFFECT OF ALKYLATION ON THE IN VITRO THYMIDINE-INCORPORATING SYSTEM OF LETTR'E-EHRLICH CELLS.
    GOLDSTEIN NO; RUTMAN RJ
    Cancer Res; 1964 Sep; 24():1363-7. PubMed ID: 14221794
    [No Abstract]   [Full Text] [Related]  

  • 8. [THE EFFECT OF ALKYLATING CYTOSTATICS ON THE NUCLEIC ACID METABOLISM OF EHRLICH ASCITES TUMOR CELLS].
    LISS E; PALME G
    Z Krebsforsch; 1964 Jul; 66():196-206. PubMed ID: 14256642
    [No Abstract]   [Full Text] [Related]  

  • 9. COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. II. THERAPEUTIC ACTIVITIES OF ALKYLATING AGENTS AND REFERENCE COMPOUNDS AGAINST VARIOUS TUMOR SYSTEMS.
    SCHMIDT LH; FRADKIN R; SULLIVAN R; FLOWERS A
    Cancer Chemother Rep; 1965 Jan; 18():SUPPL 2:403+. PubMed ID: 14278902
    [No Abstract]   [Full Text] [Related]  

  • 10. [COMPARATIVE STUDIES ON CYTOSTATIC ALKYLATING REACTIONS].
    WEITZEL G; SCHNEIDER F; FRETZDORFF AM; SEYNSCHE K; FINGER H
    Krebsforsch Krebsbekampf; 1964; 30():156-63. PubMed ID: 14283701
    [No Abstract]   [Full Text] [Related]  

  • 11. COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. I.
    SCHMIDT LH; FRADKIN R; SULLIVAN R; FLOWERS A
    Cancer Chemother Rep; 1965 Jan; 18():SUPPL 2:1-401. PubMed ID: 14278901
    [No Abstract]   [Full Text] [Related]  

  • 12. From old alkylating agents to new minor groove binders.
    Puyo S; Montaudon D; Pourquier P
    Crit Rev Oncol Hematol; 2014 Jan; 89(1):43-61. PubMed ID: 23972663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alkylation of DNA and its aftermath.
    Lawley PD
    Bioessays; 1995 Jun; 17(6):561-8. PubMed ID: 7575500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. 3. TOXICITY DATA ON MONKEYS AND DOGS.
    SCHMIDT LH; FRADKIN R; SULLIVAN R; FLOWERS A
    Cancer Chemother Rep; 1965 Jan; 18():SUPPL 2:1017+. PubMed ID: 14278900
    [No Abstract]   [Full Text] [Related]  

  • 15. THE ACTION OF ALKYLATING AGENTS ON DEOXYRIBONUCLEIC ACID IN RELATION TO BIOLOGICAL EFFECTS OF THE ALKYLATING AGENTS.
    LAWLEY PD; BROOKES P
    Exp Cell Res; 1963; 24():SUPPL9:512-20. PubMed ID: 14046250
    [No Abstract]   [Full Text] [Related]  

  • 16. Results of two years' work on the development of antitumor drugs of the type of alkylating metabolites.
    LARIONOV LF
    Cancer Chemother Rep; 1961 Apr; 11():165-75. PubMed ID: 13759109
    [No Abstract]   [Full Text] [Related]  

  • 17. THE DURATION OF THE MYELOTOXIC EFFECTS OF CIRCULATING ALKYLATING AGENTS.
    ULFOHN A; KRAMER SP; DORFMAN H; WITTEN B; WILLIAMSON C; SASS S; MILLER JI; SELIGMAN AM
    Cancer Res; 1964 Oct; 24():1659-65. PubMed ID: 14234010
    [No Abstract]   [Full Text] [Related]  

  • 18. [THE TOTAL BLOOD ALKYLATING AGENT CONCENTRATION IN RATS AFTER ADMINISTRATION OF CYCLOPHOSPHAMIDE AND ACYCLOPHOSPHAMIDE].
    RAUEN HM; KRAMER KP
    Arzneimittelforschung; 1964 Sep; 14():1066-7. PubMed ID: 14344166
    [No Abstract]   [Full Text] [Related]  

  • 19. ALKYLATING AGENTS AND IODOPHOR COMPOUNDS FOR THE PREVENTION OF LOCAL RECURRENCE OF CANCER.
    VERNICK JJ; MAGELL J; HOPPE ET
    Surg Forum; 1964; 15():336-8. PubMed ID: 14189397
    [No Abstract]   [Full Text] [Related]  

  • 20. EXPERIMENTAL CHEMOTHERAPY STUDIES. IV. THE PROTECTIVE ACTION OF MERCAPTOALKYLAMINES AGAINST ALKYLATING AGENTS.
    RUTMAN RJ; LEWIS FS; PRICE CC
    Cancer Res; 1964 May; 24():626-33. PubMed ID: 14188465
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.